Evolution of Biologics Screening Technologies.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 681, doi. 10.3390/ph6050681
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2013 AND VI 6 AND IP 5
Results: 7
1
2
FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 659, doi. 10.3390/ph6050659
- By:
- Publication type:
- Article
3
Natural Products as a Source for New Anti-Inflammatory and Analgesic Compounds through the Inhibition of Purinergic P2X Receptors.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 650, doi. 10.3390/ph6050650
- By:
- Publication type:
- Article
4
In Vivo Anti-Leukemia, Quantum Chemical Calculations and ADMET Investigations of Some Quaternary and Isothiouronium Surfactants.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 634, doi. 10.3390/ph6050634
- By:
- Publication type:
- Article
5
In Vitro Assessment of Clevidipine Using the Profilin1 Hypertensive Mouse Model.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 623, doi. 10.3390/ph6050623
- By:
- Publication type:
- Article
6
Improved Estimation of Protein-Ligand Binding Free Energy by Using the Ligand-Entropy and Mobility of Water Molecules.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 604, doi. 10.3390/ph6050604
- By:
- Publication type:
- Article
7
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 5, p. 579, doi. 10.3390/ph6050579
- By:
- Publication type:
- Article